Every earnings call for CAPLIPOINT — management tone, guidance, KPIs and promise tracking, quarter by quarter.
CAPLIPOINT · 6 transcripts · Healthcare · latest Q1 FY27Caplin Point Laboratories Limited has 6 earnings calls on record here, a Healthcare company, most recently Q1 FY27. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
EBITDA Margin 38.4%; PAT ₹179 cr (+19% YoY); Gross Margin 59.8%. Overall revenue grew by 20% YoY.
Read full transcript & analysisRevenue ₹2,300 cr (+112% YoY). Revenue doubled to INR 2,300 crores in FY26.
Read full transcript & analysisEBITDA Margin 38.5%; PAT ₹477 cr. Revenue grew by 10.6% Y-o-Y, total income by 11.2% Y-o-Y.
Read full transcript & analysisPAT ₹311 cr (+22% YoY); PBT ₹386 cr (+19% YoY). H1 FY26 revenue of ₹1,098 crores, exceeding full year FY21 revenue of ₹1,085 crores.
Read full transcript & analysisPAT ₹151 cr (+20% YoY); PAT Margin 28.1%. Overall revenue grew 11.7% YoY to ₹533 crores.
Read full transcript & analysisTotal Revenue ₹2,034 cr (+15% YoY); PAT ₹541 cr (+17% YoY); PAT Margin 26.6%. Total revenue of ₹2,034 crores, up 15% YoY for FY25.
Read full transcript & analysis